Editorial: New Approaches Against Drug-Resistant M. tuberculosis

Editorial: New Approaches Against Drug-Resistant M. tuberculosis

Bibliographic Details
Main Authors:	Yossef Av-Gay, Giorgia Mori, Maria Rosalia Pasca
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Microbiology
Subjects:	tuberculosis host directed therapy drug discovery antimicrobial resistance drug targets anti-tubercular drugs
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2021.681420/full

Similar Items

Identification of Enolase as the Target of 2-Aminothiazoles in Mycobacterium tuberculosis
by: Heather H. Wescott, et al.
Published: (2018-10-01)

Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches
by: Vinayak Singh, et al.
Published: (2021-09-01)

Study to Find Out Predisposing Factors, Causality, Severity and Avoidability of Adverse Drug Reactions among Patients Treated under DOTS Centre of Northern India
by: Sachin Tutu, et al.
Published: (2019-06-01)

Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment
by: Filia Stephanie, et al.
Published: (2021-04-01)

Adjunct therapy of Ayurvedic medicine with anti tubercular drugs on the therapeutic management of pulmonary tuberculosis
by: P K Debnath, et al.
Published: (2012-01-01)

Antimicrobial Peptides as Potential Anti-Tubercular Leads: A Concise Review
by: Gabriel S. Oliveira, et al.
Published: (2021-04-01)

Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3
by: Giulia Degiacomi, et al.
Published: (2020-01-01)

Evolving adrenal insufficiency
by: Ajitesh Roy, et al.
Published: (2012-01-01)

Mycobacterium tuberculosis Molecular Determinants of Infection, Survival Strategies, and Vulnerable Targets
by: Davide M. Ferraris, et al.
Published: (2018-02-01)

Evaluation of hepatoprotective potential of Erythrina indica leaves against antitubercular drugs induced hepatotoxicity in experimental rats
by: Mohd Mujahid, et al.
Published: (2017-01-01)

Vanishing tan and unfaithfulness
by: Jatinder K Mokta, et al.
Published: (2013-01-01)

Design, synthesis, and characterization of (1-(4-aryl)-1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis
by: Venugopala KN, et al.
Published: (2016-08-01)

Potential Impact of the Multi-Target Drug Approach in the Treatment of Some Complex Diseases
by: Makhoba XH, et al.
Published: (2020-08-01)

Tuberculosis: Past, present and future of the treatment and drug discovery research
by: Ameya D. Bendre, et al.
Published: (2021-01-01)

Optimization and validation of Mycobacterium marinum-induced adult zebrafish model for evaluation of oral anti-tuberculosis drugs
by: Jonnalagadda Padma Sridevi, et al.
Published: (2014-01-01)

SAR Analysis of Small Molecules Interfering with Energy-Metabolism in <i>Mycobacterium Tuberculosis</i>
by: Federico Appetecchia, et al.
Published: (2020-08-01)

Pangenome Analysis of Mycobacterium Tuberculosis Reveals Core-Drug Targets and Screening of Promising Lead Compounds for Drug Discovery
by: Hamza Arshad Dar, et al.
Published: (2020-11-01)

EXPERIENCE OF USING BEDAQUILINE AND LINEZOLID IN THE INTEGRAL TREATMENT OF THE PULMONARY TUBERCULOSIS PATIENT WITH EXTENSIVE DRUG RESISTANCE OF M. TUBERCULOSIS
by: E. M. Zhukova, et al.
Published: (2016-10-01)

Comparing the Daily Versus the Intermittent Regimens of the Anti-Tubercular Chemotherapy in the Initial Intensive Phase in Non-HIV, Sputum Positive, Pulmonary Tuberculosis Patients
by: Pranab Kumar Mandal, et al.
Published: (2013-02-01)

MDAD: A Special Resource for Microbe-Drug Associations
by: Ya-Zhou Sun, et al.
Published: (2018-12-01)

Novel Antimicrobials from Uncultured Bacteria Acting against Mycobacterium tuberculosis
by: Jeffrey Quigley, et al.
Published: (2020-08-01)

Search for Antimicrobial Activity Among Fifty-Two Natural and Synthetic Compounds Identifies Anthraquinone and Polyacetylene Classes That Inhibit Mycobacterium tuberculosis
by: Luiz A. E. Pollo, et al.
Published: (2021-01-01)

Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis
by: Alexander D.H. Kingdon, et al.
Published: (2021-01-01)

Drug resistance of <i>M. tuberculosis</i> (historical aspects, current level of knowledge)
by: I. A. Burmistrova, et al.
Published: (2020-02-01)

Drug-Resistant Tuberculosis in Children and Adolescents in the Republic of Sakha (Yakutia)
by: Evdokiya F. Luginova
Published: (2018-03-01)

Extensively-drug resistant tuberculosis: A new strain and future challenge
by: Ratikorn Gamngoen, et al.
Published: (2015-01-01)

Anti-tuberculosis therapy: Urgency for new drugs and integrative approach
by: Lingaraja Jena, et al.
Published: (2018-01-01)

Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery
by: Shelley E. Haydel
Published: (2010-07-01)

Opportunities for Overcoming <i>Mycobacterium tuberculosis</i> Drug Resistance: Emerging Mycobacterial Targets and Host-Directed Therapy
by: Eveline Torfs, et al.
Published: (2019-06-01)

Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs
by: Catherine Vilchèze
Published: (2020-03-01)

Anti-Tuberculosis Drug Induced Hepatotoxicity and Associated Factors among Tuberculosis Patients at Selected Hospitals, Ethiopia
by: Molla Y, et al.
Published: (2021-01-01)

Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets
by: Suhas Vasaikar, et al.
Published: (2016-11-01)

Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review
by: Vera M. Kroesen, et al.
Published: (2017-06-01)

Novel Treatments against <i>Mycobacterium tuberculosis</i> Based on Drug Repurposing
by: Álvaro Mourenza, et al.
Published: (2020-08-01)

Multi-Omics Technologies Applied to Tuberculosis Drug Discovery
by: Aaron Goff, et al.
Published: (2020-07-01)

Novel kinase platform for the validation of the anti-tubercular activities of Pelargonium sidoides (Geraniaceae)
by: V. Lukman, et al.
Published: (2020-09-01)

Investigating permeation of anti-mycobacterial agents in Mycobacterium tuberculosis and M. tuberculosis-infected macrophages in vitro as a model for early stage tuberculosis drug discovery
by: Mabhula, Amanda N
Published: (2021)

Two Decades of TB Drug Discovery Efforts—What Have We Learned?
by: Balachandra Bandodkar, et al.
Published: (2020-08-01)

Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study
by: Mehari Woldemariam Merid, et al.
Published: (2019-03-01)

An In silico approach to identify potential inhibitors against multiple drug targets of Mycobacterium tuberculosis
by: Satish Kumar, et al.
Published: (2019-01-01)